-
Dietary interventions in cancer: a systematic review of all randomized controlled trials. J Natl Cancer Inst. 2024 Mar 01.
Ilerhunmwuwa NP, Abdul Khader AHS, Smith C, Cliff ERS, Booth CM, Rd EH, Aziz M, Lee-Smith W, Goodman A, Chakraborty R, Mohyuddin GR. PMID: 38429997.
View in:
PubMed Mentions: Fields:
-
Use of subjective minimizing language at hematology and oncology conferences: A systematic review. J Cancer Policy. 2023 Dec 05; 39:100461.
Abusamak AA, Abusamak M, Al-Abbadi M, Rayyan A, Oran O, Mohyuddin GR, Kelkar AH, Goodman AM, Chakraborty R, Cliff ERS, Al Hadidi S. PMID: 38061494.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma. JAMA Netw Open. 2023 Nov 01; 6(11):e2342195.
Najjar M, McCarron J, Cliff ERS, Berger K, Steensma DP, Al Hadidi S, Chakraborty R, Goodman A, Anto E, Greene T, Sborov D, Mohyuddin GR. PMID: 37948080; PMCID: PMC10638643.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review. JNCI Cancer Spectr. 2023 Oct 31; 7(6).
Alrawabdeh J, Alzu'bi M, Alzyoud M, Odeh N, Hamadneh Y, Mian H, Mohyuddin GR, Kelkar AH, Goodman AM, Chakraborty R, Russler-Germain DA, Mehra N, Baggio D, Cliff ERS, Al Hadidi S. PMID: 38006333.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Common Sense Oncology: including everyone - Authors' reply. Lancet Oncol. 2023 Oct; 24(10):e404.
Booth CM, Sengar M, Goodman A, Wilson B, Gyawali B. PMID: 37797642.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience. Cancers (Basel). 2023 Sep 21; 15(18).
Trando A, Ter-Zakarian A, Yeung P, Goodman AM, Hamdan A, Hurley M, Jeong AR, Tzachanis D. PMID: 37760639; PMCID: PMC10527363.
View in:
PubMed Mentions:
-
#MedEd: Medical Education and Knowledge Translation on Social Media. JAMA. 2023 09 12; 330(10):909-910.
Ayers JW, Goodman AM, Smith DM. PMID: 37642959; PMCID: PMC10792539.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. Blood Adv. 2023 08 08; 7(15):3984-3992.
Aaroe A, Kurzrock R, Goyal G, Goodman AM, Patel H, Ruan G, Ulaner G, Young J, Li Z, Dustin D, Go RS, Diamond EL, Janku F. PMID: 36857436; PMCID: PMC10410131.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Common Sense Oncology: outcomes that matter. Lancet Oncol. 2023 08; 24(8):833-835.
Booth CM, Sengar M, Goodman A, Wilson B, Aggarwal A, Berry S, Collingridge D, Denburg A, Eisenhauer EA, Ginsburg O, Goldstein D, Gunasekera S, Hammad N, Honda K, Jackson C, Karikios D, Knopf K, Koven R, Marini BL, Maskens D, Moraes FY, Mohyuddin GR, Poudyal BS, Pramesh CS, Roitberg F, Rubagumya F, Schott S, Sirohi B, Soto-Perez-de-Celis E, Sullivan R, Tannock IF, Trapani D, Tregear M, van der Graaf W, Vanderpuye V, Gyawali B. PMID: 37467768.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
The essential role of randomised controlled trials. Lancet Haematol. 2023 07; 10(7):e486-e487.
Marini BL, Goodman AM, Perissinotti AJ. PMID: 37407137.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review. Eur J Haematol. 2023 Sep; 111(3):491-498.
Hentzen S, Meirson T, Koehn K, Goodman A, Chakraborty R, Sborov D, Rubinstein S, Mohyuddin GR. PMID: 37382045.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
First use of ibrutinib for the treatment of post-transplant central nervous system graft-versus-host disease. Br J Haematol. 2023 09; 202(5):1061-1064.
Trando A, Dunn-Pirio A, Koura D, Goodman AM. PMID: 37357559.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity. Ecancermedicalscience. 2023; 17:1558.
Sengar M, Hopman WM, Mohyuddin GR, Goodman AM, Gyawali B, Mukherji D, Hammad N, Pramesh CS, Aggarwal A, Sullivan R, Booth CM. PMID: 37396096; PMCID: PMC10310333.
View in:
PubMed Mentions:
-
Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum. JAMA Intern Med. 2023 06 01; 183(6):589-596.
Ayers JW, Poliak A, Dredze M, Leas EC, Zhu Z, Kelley JB, Faix DJ, Goodman AM, Longhurst CA, Hogarth M, Smith DM. PMID: 37115527; PMCID: PMC10148230.
View in:
PubMed Mentions:
157 Fields:
Translation:
Humans
-
Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse. J Immunother Precis Oncol. 2023 Aug; 6(3):127-132.
Castro A, Goodman AM, Rane Z, Talwar JV, Frampton GM, Morris GP, Lippman SM, Zhang X, Kurzrock R, Carter H. PMID: 37637234; PMCID: PMC10448732.
View in:
PubMed Mentions:
-
The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma. Clin Hematol Int. 2023 Jun; 5(2-3):170-176.
Tariq SM, Abdallah AO, Goodman A, Sborov D, Mohyuddin GR, Britt A. PMID: 37133718; PMCID: PMC10241733.
View in:
PubMed Mentions:
-
Ineligible for transplant, but eligible for intensive quadruplet therapy-The value of 'add-on' trials for vulnerable patient populations. Eur J Cancer. 2023 May; 185:164-166.
Mohyuddin GR, Goodman AM. PMID: 36996626.
View in:
PubMed Mentions: Fields:
-
Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology. J Cancer Policy. 2023 06; 36:100411.
Sharma N, Wayant C, Neupane K, Lenka J, Berger K, Goodman AM, Booth CM, Prasad V, Mohyuddin GR. PMID: 36773798.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Analysis of repeated roles in editorial boards at oncology focused journals. J Cancer Policy. 2023 03; 35:100380.
Sawalha L, Kelkar AH, Mohyuddin GR, Goodman AM, Gagelmann N, Al Hadidi S. PMID: 36538988.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis. Br J Haematol. 2023 03; 200(5):587-594.
Etekal T, Koehn K, Sborov DW, McClune B, Prasad V, Haslam A, Berger K, Booth C, Al Hadidi S, Abdallah AO, Goodman A, Mohyuddin GR. PMID: 36495317.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015-2020. Blood Cancer J. 2022 11 15; 12(11):155.
Van Oekelen O, Birrer N, Wesson W, Galate VL, Cliff ERS, Goodman AM, Abdallah AO, Chakraborty R, Prasad V, Mohyuddin GR. PMID: 36379917; PMCID: PMC9666639.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy. J Immunother Precis Oncol. 2022 Nov; 5(4):90-97.
Bevins NJ, Okamura R, Montesion M, Adashek JJ, Goodman AM, Kurzrock R. PMID: 36483582; PMCID: PMC9714418.
View in:
PubMed Mentions:
4
-
Ivosidenib and Azacitidine in IDH1-Mutated AML. N Engl J Med. 2022 06 30; 386(26):2536.
Goodman AM, Mohyuddin GR, Prasad V. PMID: 35767449.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma. Transplant Cell Ther. 2022 08; 28(8):487.e1-487.e7.
Munshi PN, Chen Y, Ahn KW, Awan FT, Cashen A, Shouse G, Shadman M, Shaughnessy P, Zurko J, Locke FL, Goodman AM, Bisneto JCV, Sauter C, Kharfan-Dabaja MA, Meyers G, Jaglowski S, Herrera A, Hamadani M. PMID: 35609865; PMCID: PMC9375438.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Age-Adjusted Schedules of Venetoclax and Hypomethylating Agents to Treat Extremely Elderly Patients with Acute Myeloid Leukemia. Case Rep Hematol. 2022; 2022:2802680.
Lee AM, Goodman AM, Mangan JK. PMID: 35515507; PMCID: PMC9064535.
View in:
PubMed Mentions:
1
-
Effects of financial toxicity on prescription drug use and mental well-being in cancer patients. Explor Res Clin Soc Pharm. 2022 Jun; 6:100136.
Chan K, Sepassi A, Saunders IM, Goodman A, Watanabe JH. PMID: 35909716; PMCID: PMC9335927.
View in:
PubMed Mentions:
2
-
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 03; 20(3):285-308.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H. PMID: 35276674.
View in:
PubMed Mentions:
40 Fields:
Translation:
Humans
-
Post-protocol therapy and informative censoring in the CANDOR study. Lancet Oncol. 2022 03; 23(3):e97.
Meirson T, Markel G, Prasad V, Goodman AM, Mohyuddin GR. PMID: 35240098.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Heterogeneity of enrolment criteria for ongoing smouldering myeloma trials. Br J Haematol. 2022 06; 197(6):e86-e88.
Soomro MA, Hoffman J, Goodman AM, Sborov DW, Mohyuddin GR. PMID: 35229286.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Characteristics of clinical trials for haematological malignancies from 2015 to 2020: A systematic review. Eur J Cancer. 2022 05; 167:152-160.
Wesson W, Galate VL, Sborov DW, McClune B, Goodman AM, Gyawali B, Prasad V, Abbasi S, Mohyuddin GR. PMID: 35236569.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. Br J Haematol. 2022 04; 197(1):63-70.
On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. PMID: 35174480.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Synthetic control arms in studies of multiple myeloma and diffuse large B-cell lymphoma. Br J Haematol. 2022 03; 196(5):1274-1277.
Banerjee R, Midha S, Kelkar AH, Goodman A, Prasad V, Mohyuddin GR. PMID: 34750805.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 11; 19(11):1277-1303.
Go RS, Jacobsen E, Baiocchi R, Buhtoiarov I, Butler EB, Campbell PK, Coulter DW, Diamond E, Flagg A, Goodman AM, Goyal G, Gratzinger D, Hendrie PC, Higman M, Hogarty MD, Janku F, Karmali R, Morgan D, Raldow AC, Stefanovic A, Tantravahi SK, Walkovich K, Zhang L, Bergman MA, Darlow SD. PMID: 34781268.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
Practicing on the edge of oncology: when standard of care feels uncomfortable. Nat Rev Clin Oncol. 2021 11; 18(11):673-674.
Booth CM, Goodman AM. PMID: 34385680.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Perils of Ignoring Overall Survival in Interpreting the Myeloma Literature. J Clin Oncol. 2022 01 01; 40(1):105-106.
Mohyuddin GR, Goodman AM, Knopf K. PMID: 34652953.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. Transplant Cell Ther. 2022 01; 28(1):30.e1-30.e7.
Goodman AM, Holden KA, Jeong AR, Kim L, Fitzgerald KD, Almasri E, McLennan G, Eisenberg M, Jahromi AH, Hoh C, Hurley M, Mulroney C, Tzachanis D, Ball ED, Jensen TJ, Kurzrock R. PMID: 34655803.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers. Genome Med. 2021 10 12; 13(1):159.
Pham TV, Goodman AM, Sivakumar S, Frampton G, Kurzrock R. PMID: 34641956; PMCID: PMC8513181.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Novel somatic alterations in unicentric and idiopathic multicentric Castleman disease. Eur J Haematol. 2021 Dec; 107(6):642-649.
Goodman AM, Jeong AR, Phillips A, Wang HY, Sokol ES, Cohen PR, Sicklick J, Fajgenbaum DC, Kurzrock R. PMID: 34431136; PMCID: PMC9624446.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Lack of equipoise in the LIGHTHOUSE trial for patients with relapsed multiple myeloma: An ethical concern. Eur J Cancer. 2021 11; 157:533-535.
Mohyuddin GR, Banerjee R, Goodman AM. PMID: 34544634.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
FMS-Like Tyrosine Kinase 3 Inhibitors for the Treatment of Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2022 03; 22(3):e161-e184.
Novatcheva ED, Anouty Y, Saunders I, Mangan JK, Goodman AM. PMID: 34649791.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. Mol Cancer Ther. 2021 11; 20(11):2274-2279.
Jensen TJ, Goodman AM, Ellison CK, Holden KA, Kato S, Kim L, Daniels GA, Fitzgerald K, McCarthy E, Nakashe P, Mazloom AR, Almasri E, McLennan G, Grosu DS, Eisenberg M, Kurzrock R. PMID: 34465593.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Intention to treat versus modified intention-to-treat analysis in B-cell maturation antigen and CD19 chimeric antigen receptor trials: A systematic review and meta-analysis. Eur J Cancer. 2021 10; 156:164-174.
Mohyuddin GR, Atieh T, Ahmed N, Sborov D, McClune B, Abdallah AO, Goodman AM, Aziz M, Allen I, Prasad V. PMID: 34454318.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCells
-
The landscape of trials for smoldering multiple myeloma: endpoints, trial design, and lessons learnt. Leuk Lymphoma. 2021 11; 62(11):2793-2795.
Mohyuddin GR, Ouchveridze E, Goodman A, Prasad V. PMID: 34114943.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Multiple myeloma triplet therapies: baseline characteristics and control groups. Lancet. 2021 05 01; 397(10285):1620-1621.
Mohyuddin GR, Abdallah AO, McClune B, Goodman A, Prasad V. PMID: 33933200.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Rosai-Dorfman-Destombes (RDD) disease presenting as palindromic rheumatism. BMC Med Imaging. 2021 04 15; 21(1):72.
Haghighat Jahromi A, Goodman AM, Hoh CK. PMID: 33858362; PMCID: PMC8050901.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials: A Systematic Review. JAMA Netw Open. 2021 04 01; 4(4):e218084.
Mohyuddin GR, Koehn K, Abdallah AO, Goodman AM, Prasad V. PMID: 33909053; PMCID: PMC8082314.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review. Lancet Haematol. 2021 Apr; 8(4):e299-e304.
Mohyuddin GR, Koehn K, Sborov D, McClune B, Abdallah AO, Goodman AM, Prasad V. PMID: 33770485.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
STK11 alterations in the pan-cancer setting: prognostic and therapeutic implications. Eur J Cancer. 2021 05; 148:215-229.
Krishnamurthy N, Goodman AM, Barkauskas DA, Kurzrock R. PMID: 33744718; PMCID: PMC10344467.
View in:
PubMed Mentions:
16 Fields:
Translation:
Humans
-
Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. Front Oncol. 2021; 11:620435.
Wang HY, Sokol ES, Goodman AM, Feldman AL, Mulroney CM. PMID: 33777766; PMCID: PMC7988195.
View in:
PubMed Mentions:
1
-
Persistent challenges with treating multiple myeloma early. Blood. 2021 01 28; 137(4):456-458.
Goodman AM, Kim MS, Prasad V. PMID: 33236046.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors? Clin Med Insights Oncol. 2020; 14:1179554920976366.
Jeong AR, Ball ED, Goodman AM. PMID: 33447123; PMCID: PMC7780174.
View in:
PubMed Mentions:
5
-
Cutaneous intralymphatic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma arising in a patient with multiple rounds of breast implants. J Cutan Pathol. 2021 May; 48(5):659-662.
Wang HY, Thorson JA, Hinds BR, Swalchick W, Parker BA, Chong A, Wallace AM, Goodman AM. PMID: 33314229.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients. EJNMMI Res. 2020 Dec 09; 10(1):150.
Haghighat Jahromi A, Barkauskas DA, Zabel M, Goodman AM, Frampton G, Nikanjam M, Hoh CK, Kurzrock R. PMID: 33296034; PMCID: PMC7726049.
View in:
PubMed Mentions:
6
-
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021. J Natl Compr Canc Netw. 2020 11 02; 18(11):1460-1467.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kim YH, Mehta-Shah N, Olsen EA, Pro B, Rajguru SA, Rozati S, Said J, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H. PMID: 33152703.
View in:
PubMed Mentions:
20 Fields:
Translation:
Humans
-
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. Cancer Cell. 2021 02 08; 39(2):154-173.
Jardim DL, Goodman A, de Melo Gagliato D, Kurzrock R. PMID: 33125859; PMCID: PMC7878292.
View in:
PubMed Mentions:
337 Fields:
Translation:
HumansCells
-
Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults. Expert Opin Biol Ther. 2021 07; 21(7):849-862.
Goldenson BH, Goodman AM, Ball ED. PMID: 32990476.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy. Nat Commun. 2020 10 02; 11(1):4965.
Kato S, Kim KH, Lim HJ, Boichard A, Nikanjam M, Weihe E, Kuo DJ, Eskander RN, Goodman A, Galanina N, Fanta PT, Schwab RB, Shatsky R, Plaxe SC, Sharabi A, Stites E, Adashek JJ, Okamura R, Lee S, Lippman SM, Sicklick JK, Kurzrock R. PMID: 33009371; PMCID: PMC7532150.
View in:
PubMed Mentions:
103 Fields:
Translation:
Humans
-
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. Am J Hematol. 2020 12; 95(12):1553-1561.
Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffmann C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F, Castleman Disease Collaborative Network Scientific Advisory Board diagnostic criteria international . PMID: 32894785; PMCID: PMC9547644.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansCTClinical Trials
-
High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers. Mol Cancer Ther. 2020 10; 19(10):2139-2145.
Riviere P, Goodman AM, Okamura R, Barkauskas DA, Whitchurch TJ, Lee S, Khalid N, Collier R, Mareboina M, Frampton GM, Fabrizio D, Sharabi AB, Kato S, Kurzrock R. PMID: 32747422; PMCID: PMC7541603.
View in:
PubMed Mentions:
36 Fields:
Translation:
Humans
-
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy. Mol Oncol. 2020 08; 14(8):1680-1694.
Pham TV, Boichard A, Goodman A, Riviere P, Yeerna H, Tamayo P, Kurzrock R. PMID: 32530570; PMCID: PMC7400787.
View in:
PubMed Mentions:
19 Fields:
Translation:
Humans
-
Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy. Cureus. 2020 Jul 02; 12(7):e8967.
Cohen PR, Nikanjam M, Kato S, Goodman AM, Kurzrock R. PMID: 32766009; PMCID: PMC7398726.
View in:
PubMed Mentions:
1
-
Characterization of relapse patterns in patients with acute lymphoblastic leukemia treated with blinatumomab. J Oncol Pharm Pract. 2021 Jun; 27(4):821-826.
Lau KM, Saunders IM, Goodman AM. PMID: 32605497.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Tumor mutational burden is not predictive of cytotoxic chemotherapy response. Oncoimmunology. 2020 06 24; 9(1):1781997.
Nikanjam M, Riviere P, Goodman A, Barkauskas DA, Frampton G, Kurzrock R. PMID: 32923144; PMCID: PMC7458654.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020 05 28; 135(22):1929-1945.
Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, Hershkovitz-Rokah O, Girschikofsky M, Jacobsen ED, Toyama K, Goodman AM, Hendrie P, Cao XX, Estrada-Veras JI, Shpilberg O, Abdo A, Kurokawa M, Dagna L, McClain KL, Mazor RD, Picarsic J, Janku F, Go RS, Haroche J, Diamond EL. PMID: 32187362.
View in:
PubMed Mentions:
91 Fields:
Translation:
HumansCells
-
MHC-I genotype and tumor mutational burden predict response to immunotherapy. Genome Med. 2020 05 19; 12(1):45.
Goodman AM, Castro A, Pyke RM, Okamura R, Kato S, Riviere P, Frampton G, Sokol E, Zhang X, Ball ED, Carter H, Kurzrock R. PMID: 32430031; PMCID: PMC7236948.
View in:
PubMed Mentions:
45 Fields:
Translation:
Humans
-
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. J Natl Compr Canc Netw. 2020 05; 18(5):522-536.
Mehta-Shah N, Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Fisher K, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Lunning MA, Mehta A, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H, Kim YH. PMID: 32380458.
View in:
PubMed Mentions:
35 Fields:
Translation:
Humans
-
An IgA plasmacytoma: a rare and distinct form of plasmacytoma. Blood. 2020 04 23; 135(17):1505.
Wang HY, Goodman AM. PMID: 32324872.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Total Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced Cancers. JCO Precis Oncol. 2020; 4.
Vu P, Khagi Y, Riviere P, Goodman A, Kurzrock R. PMID: 32923910; PMCID: PMC7450932.
View in:
PubMed Mentions:
11 Fields:
-
Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity. Oncoimmunology. 2020; 9(1):1708065.
Kato S, Okamura R, Kumaki Y, Ikeda S, Nikanjam M, Eskander R, Goodman A, Lee S, Glenn ST, Dressman D, Papanicolau-Sengos A, Lenzo FL, Morrison C, Kurzrock R. PMID: 32117584; PMCID: PMC7028323.
View in:
PubMed Mentions:
30 Fields:
Translation:
HumansCells
-
Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies. Int J Cancer. 2020 06 15; 146(12):3450-3460.
Kato S, Okamura R, Sicklick JK, Daniels GA, Hong DS, Goodman A, Weihe E, Lee S, Khalid N, Collier R, Mareboina M, Riviere P, Whitchurch TJ, Fanta PT, Lippman SM, Kurzrock R. PMID: 31782524; PMCID: PMC10200262.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCells
-
Real-World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim-Chester Disease. Oncologist. 2020 02; 25(2):e386-e390.
Saunders IM, Goodman AM, Kurzrock R. PMID: 32043767; PMCID: PMC7011668.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2020 07; 20(7):431-437.e2.
Klebaner D, Koura D, Tzachanis D, Ball ED, Horwitz S, Goodman AM. PMID: 32284297.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy. Cancer Immunol Res. 2019 10; 7(10):1570-1573.
Goodman AM, Sokol ES, Frampton GM, Lippman SM, Kurzrock R. PMID: 31405947; PMCID: PMC6774837.
View in:
PubMed Mentions:
132 Fields:
Translation:
HumansCells
-
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma. Oncotarget. 2019 Jun 18; 10(40):4018-4025.
Ang C, Klempner SJ, Ali SM, Madison R, Ross JS, Severson EA, Fabrizio D, Goodman A, Kurzrock R, Suh J, Millis SZ. PMID: 31258846; PMCID: PMC6592287.
View in:
PubMed Mentions:
79 Fields:
-
Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies. J Oncol Pharm Pract. 2020 Mar; 26(2):351-360.
Kim S, Namba J, Goodman AM, Nguyen T, Saunders IM. PMID: 31142232.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis. Mol Cancer Ther. 2019 06; 18(6):1149-1157.
Janku F, Diamond EL, Goodman AM, Raghavan VK, Barnes TG, Kato S, Abdel-Wahab O, Durham BH, Meric-Bernstam F, Kurzrock R. PMID: 31015311; PMCID: PMC6548628.
View in:
PubMed Mentions:
15 Fields:
Translation:
Humans
-
Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness. Cancer Immunol Res. 2019 06; 7(6):866-873.
Goodman AM, Kato S, Chattopadhyay R, Okamura R, Saunders IM, Montesion M, Frampton GM, Miller VA, Daniels GA, Kurzrock R. PMID: 31003990; PMCID: PMC6548620.
View in:
PubMed Mentions:
16 Fields:
Translation:
Humans
-
Schnitzler syndrome associated with MYD88 L265P mutation. JAAD Case Rep. 2019 Apr; 5(4):312-316.
Goodman AM, Cohen PR, Li A, Hinds B, Kurzrock R. PMID: 30989098; PMCID: PMC6446129.
View in:
PubMed Mentions:
3
-
Immune Escape of AML Cells after Transplantation. N Engl J Med. 2019 03 28; 380(13):1289.
Goodman AM, Kurzrock R. PMID: 30917272.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia. J Oncol Pharm Pract. 2020 Jan; 26(1):193-199.
Lau KM, Saunders IM, Goodman A. PMID: 30823860.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies. JCO Precis Oncol. 2019; 3.
Kato S, Okamura R, Mareboina M, Lee S, Goodman A, Patel SP, Fanta PT, Schwab RB, Vu P, Raymond VM, Lanman RB, Sicklick JK, Lippman SM, Kurzrock R. PMID: 31058253; PMCID: PMC6497417.
View in:
PubMed Mentions:
37 Fields:
-
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. Oncoimmunology. 2019; 8(3):1550341.
Boichard A, Pham TV, Yeerna H, Goodman A, Tamayo P, Lippman S, Frampton GM, Tsigelny IF, Kurzrock R. PMID: 30723579; PMCID: PMC6350681.
View in:
PubMed Mentions:
37 Fields:
-
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. Cancers (Basel). 2018 Dec 21; 11(1).
Galanina N, Bejar R, Choi M, Goodman A, Wieduwilt M, Mulroney C, Kim L, Yeerna H, Tamayo P, Vergilio JA, Mughal TI, Miller V, Jamieson C, Kurzrock R. PMID: 30583461; PMCID: PMC6356731.
View in:
PubMed Mentions:
13
-
Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients. Mol Cancer Ther. 2019 02; 18(2):448-458.
Jensen TJ, Goodman AM, Kato S, Ellison CK, Daniels GA, Kim L, Nakashe P, McCarthy E, Mazloom AR, McLennan G, Grosu DS, Ehrich M, Kurzrock R. PMID: 30523049.
View in:
PubMed Mentions:
46 Fields:
Translation:
HumansCells
-
GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. Cancer. 2018 10 15; 124(20):4080-4089.
Parish AJ, Nguyen V, Goodman AM, Murugesan K, Frampton GM, Kurzrock R. PMID: 30204251; PMCID: PMC6234097.
View in:
PubMed Mentions:
24 Fields:
Translation:
Humans
-
Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade. Cancer Immunol Res. 2018 10; 6(10):1129-1135.
Galanina N, Goodman AM, Cohen PR, Frampton GM, Kurzrock R. PMID: 30194084; PMCID: PMC6248326.
View in:
PubMed Mentions:
39 Fields:
Translation:
Humans
-
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018 11 15; 132(20):2115-2124.
van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. PMID: 30181172; PMCID: PMC6238190.
View in:
PubMed Mentions:
133 Fields:
Translation:
Humans
-
Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors. JAMA Oncol. 2018 09 01; 4(9):1237-1244.
Goodman AM, Piccioni D, Kato S, Boichard A, Wang HY, Frampton G, Lippman SM, Connelly C, Fabrizio D, Miller V, Sicklick JK, Kurzrock R. PMID: 29902298; PMCID: PMC6139049.
View in:
PubMed Mentions:
133 Fields:
Translation:
Humans
-
Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies. Oncoimmunology. 2018; 7(3):e1404217.
Goodman AM, Kato S, Cohen PR, Boichard A, Frampton G, Miller V, Stephens PJ, Daniels GA, Kurzrock R. PMID: 29399405; PMCID: PMC5790366.
View in:
PubMed Mentions:
29 Fields:
-
Erythrodermic Psoriasis in a Man with Monoclonal B-cell Lymphocytosis. Cureus. 2017 Dec 11; 9(12):e1936.
Chen SX, Hinds BR, Goodman AM, Cohen PR. PMID: 29464143; PMCID: PMC5807020.
View in:
PubMed Mentions:
1
-
View in:
PubMed Mentions:
114 Fields:
Translation:
Humans
-
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers. Mol Cancer Ther. 2017 11; 16(11):2598-2608.
Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens PJ, Daniels GA, Kurzrock R. PMID: 28835386; PMCID: PMC5670009.
View in:
PubMed Mentions:
1096 Fields:
Translation:
HumansAnimalsCells
-
Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease. Int J Mol Sci. 2017 Jul 31; 18(8).
Cohen PR, Kato S, Goodman AM, Ikeda S, Kurzrock R. PMID: 28788102; PMCID: PMC5578053.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies. JCO Precis Oncol. 2017 06; 1.
Goodman AM, Choi M, Wieduwilt M, Mulroney C, Costello C, Frampton G, Miller V, Kurzrock R. PMID: 28681041; PMCID: PMC5495179.
View in:
PubMed Mentions:
14 Fields:
-
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate. Clin Cancer Res. 2017 Aug 01; 23(15):4242-4250.
Kato S, Goodman A, Walavalkar V, Barkauskas DA, Sharabi A, Kurzrock R. PMID: 28351930; PMCID: PMC5647162.
View in:
PubMed Mentions:
438 Fields:
Translation:
Humans
-
What are the latest advancements in acute myeloid leukemia therapy? Future Oncol. 2017 Apr; 13(10):867-871.
Goodman A, Ball ED. PMID: 28266249.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis. Oncology (Williston Park). 2017 02 15; 31(2):122-4, 126-8.
Goodman AM, Rust M, Costello C, Ball ED. PMID: 28205192.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas. Nat Rev Clin Oncol. 2017 04; 14(4):203-220.
Goodman A, Patel SP, Kurzrock R. PMID: 27805626.
View in:
PubMed Mentions:
225 Fields:
Translation:
Humans
-
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy. NPJ Genom Med. 2016; 1.
Ikeda S, Goodman AM, Cohen PR, Jensen TJ, Ellison CK, Frampton G, Miller V, Patel SP, Kurzrock R. PMID: 27942391; PMCID: PMC5142752.
View in:
PubMed Mentions:
55
-
An 84-Year-Old Woman With an Indolent B-Cell Lymphoma. Oncology (Williston Park). 2016 08 15; 30(8):705-8, 710, 712.
Goodman AM, Choi M, Wang L, Kurzrock R. PMID: 27535668.
View in:
PubMed Mentions: Fields:
Translation:
Humans